Palisade Bio (PALI) Acquisitions (2021)
Palisade Bio (PALI) reported Acquisitions of -$54000.0 for Q4 2021, down 115.52% quarter-over-quarter from $348000.0 in Q3 2021.
Palisade Bio (PALI) Acquisitions (2021) Analysis & Trends
Palisade Bio (PALI) has 1 years of Acquisitions data on file, last reported at -$54000.0 in Q4 2021.
- Acquisitions for Q4 2021 came in at -$54000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $294000.0 (changed 0.0% YoY), and the FY2021 annual result was $3.3 million, changed N/A from the prior year.
- Acquisitions slipped to -$54000.0 in Q4 2021 per PALI's latest filing, from $348000.0 in the prior quarter.
- Over five years, Acquisitions peaked at $348000.0 in Q3 2021 and troughed at -$54000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | 348,000.00 |